Atara Biotherapeutics
ATRA
ATRA
122 hedge funds and large institutions have $1.13B invested in Atara Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
10% more funds holding
Funds holding: 111 → 122 (+11)
0.04% more ownership
Funds ownership: 4.29% → 4.34% (+0.04%)
Holders
122
Holding in Top 10
3
Calls
$1.5M
Puts
$746K
Top Buyers
| 1 | +$76.3M | |
| 2 | +$42.2M | |
| 3 | +$23.5M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$22.6M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$22.6M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$39.1M | |
| 3 | -$14.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$12.8M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$9.49M |